Get insights into next week's stock market movers, IPOs, earnings reports, Federal Reserve events, and economic forecasts.

For FY25, monday.com has raised its full-year guidance outlook to $1.22-$1.226 billion in revenue, representing a 25-26% y/y ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

AI workload demands continue to expand, with generative AI a driver of further investment in infrastructure. As organizations ...

The benefits of financial independence extend far beyond the financial realm. Read about three undervalued dividend growth ...

Amazon's balance sheet is one of the strongest on the planet, boasting an AA credit rating from S&P on a stable outlook. Read ...

Milei, but faces credit risks, lower margins, and valuation concerns despite macro tailwinds. Find out why BBAR stock is a ...

Macy’s faces core sales pressure and leadership uncertainty despite luxury strength, dimming its near-term outlook and ...

Kanzhun posted strong Q1 results with solid user growth, but macro risks in China cloud the outlook despite AI tailwinds.

Adoption of generative AI has exceeded even the ambitious strategies set by organizations in 2024. The technology has been ...

Q1 2026 results, but improving profitability and low valuations support long-term upside amid transition. See why CRM stock ...

Zeta's growth and AI adoption signal strong future prospects despite past challenges. Read here to know why we recommend a ...